VA

Valneva SE

  • CIK: 0001836564
  • EIN: 00-0000000
  • Business address: 6, RUE ALAIN BOMBARD, SAINT-HERBLAIN, France, 44800

Information

  • Mailing address
    6, RUE ALAIN BOMBARD, SAINT-HERBLAIN, France, 44800
  • Phone
    33 2 28 07 37 10
  • State location
    France
  • State of incorporation
    France
  • Fiscal year end
    December 31
  • SIC
    2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • Filings
    N/A

About Valneva SE

Valneva SE (CIK: 0001836564) is an American company incorporated in the state of France. Head office is located at 6, RUE ALAIN BOMBARD, SAINT-HERBLAIN, France, 44800. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Valneva SE is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Valneva SE

Filings Format Description Filed/Effective File/Film Number
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-001579 (34 Act) Size: 23 KB		 Mar-26-2024

001-40377

24780859
20-F Document

Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d)

Acc-no: 0001628280-24-012747 (34 Act) Size: 22320 KB		 Mar-22-2024

001-40377

24776154
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-001522 (34 Act) Size: 14 KB		 Mar-22-2024

001-40377

24772512
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-001484 (34 Act) Size: 149 KB		 Mar-20-2024

001-40377

24767180
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-001414 (34 Act) Size: 14 KB		 Mar-19-2024

001-40377

24760552
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-001165 (34 Act) Size: 11 KB		 Mar-04-2024

001-40377

24715423
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-001087 (34 Act) Size: 17 KB		 Feb-29-2024

001-40377

24702957
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-000821 (34 Act) Size: 21 KB		 Feb-15-2024

001-40377

24642002
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001172661-24-000947 (34 Act) Size: 101 KB		 Feb-14-2024

005-93388

24632751
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-000572 (34 Act) Size: 16 KB		 Feb-05-2024

001-40377

24593819
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-000180 (34 Act) Size: 18 KB		 Jan-10-2024

001-40377

24525763
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-24-000114 (34 Act) Size: 12 KB		 Jan-08-2024

001-40377

24518389
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-23-007732 (34 Act) Size: 14 KB		 Dec-29-2023

001-40377

231528536
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-23-007669 (34 Act) Size: 14 KB		 Dec-21-2023

001-40377

231505196
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-23-007431 (34 Act) Size: 41 KB		 Dec-05-2023

001-40377

231465313
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-23-007279 (34 Act) Size: 19 KB		 Nov-27-2023

001-40377

231439082
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-23-007123 (34 Act) Size: 14 KB		 Nov-15-2023

001-40377

231409817
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-23-006992 (34 Act) Size: 42 KB		 Nov-13-2023

001-40377

231394722
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001628280-23-038086 (34 Act) Size: 1892 KB		 Nov-09-2023

001-40377

231390620
6-K Document

Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Acc-no: 0001171843-23-006834 (34 Act) Size: 12 KB		 Nov-07-2023

001-40377

231384911

Recent 20 filings. View all Valneva SE filings

Reviews

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Frequently Asked Questions

Tags:

  • Valneva SE overview
  • Valneva SE job
  • Valneva SE stock
  • Valneva SE ownership
  • Valneva SE CEO
  • Valneva SE documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Inhibrx Biosciences, Inc.
Update: Apr 26, 2024
CG Oncology, Inc.
Update: Jan 03, 2024
Iris Parent Holding Corp.
Update: Nov 09, 2023
Kyverna Therapeutics, Inc.
Update: Nov 08, 2023
Sequoia Vaccines, Inc.
Update: Nov 07, 2023
Lexeo Therapeutics, Inc.
Update: Nov 02, 2023

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 2707 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 1250 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 4293 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 1436 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 4098 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 1357 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 3183 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 2202 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 4584 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by